Journal Report

Drugs of the Future

Download PDF
Journal Information
Journal Title
Drugs of the Future
Publisher
Clarivate
ISSN
0377-8282
E-ISSN
2013-0368
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026
2025 ✓
2024
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
Pamela Brown, Andy Merritt, Sarah Skerratt et al.
2023-3 Vol. 48 Issue 3 Pages 211-219
DOI: 10.1358/dof.2023.48.3.3567668
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
Thomas L. Jensen, Andreas Brønden, Kristian Karstoft et al.
2023-3 Vol. 48 Issue 3 Pages 179-196
DOI: 10.1358/dof.2023.48.3.3521861
Pipeline on the Move
Laura Fernández Bertolín
2023-3 Vol. 48 Issue 3 Pages 197-210
DOI: 10.1358/dof.2023.48.3.3560010
Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases
Valdemar W. Nielsen, Yiqiu Yao, Alexander Egeberg et al.
2023-3 Vol. 48 Issue 3 Pages 165-172
DOI: 10.1358/dof.2023.48.3.3500035
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
Chiara Tarantelli, Francesco Bertoni
2023-3 Vol. 48 Issue 3 Pages 155-164
DOI: 10.1358/dof.2023.48.3.3509749
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
Glenda Walker, Mithila Sridevi
2023-3 Vol. 48 Issue 3 Pages 221-226
DOI: 10.1358/dof.2023.48.3.3560011
Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration
Sabrina Vaccaro, Lorenzo Ferro Desideri, Pietro Bianchi et al.
2023-3 Vol. 48 Issue 3 Pages 173-177
DOI: 10.1358/dof.2023.48.3.3474539
Ancremonam. Monobactam, Treatment of multidrug-resistant Enterobacteriaceae infections
Mohammad N. Ahmad, Arunava Dasgupta, Sidharth Chopra
2023-2 Vol. 48 Issue 2 Pages 81-91
DOI: 10.1358/dof.2023.48.2.3400571
American Heart Association (AHA) Scientific Sessions - 2022 Annual Meeting. Chicago/Virtual - November 5-7, 2022
Dhivya Soundararajan
2023-2 Vol. 48 Issue 2 Pages 141-147
DOI: 10.1358/dof.2023.48.2.3521848
Tozorakimab. Anti-IL-33 monoclonal antibody, Treatment of COPD and asthma, Treatment of atopic dermatitis, Treatment of diabetic kidney disease
Mario Cazzola, Paola Rogliani, Luigino Calzetta et al.
2023-2 Vol. 48 Issue 2 Pages 101-109
DOI: 10.1358/dof.2023.48.2.3474010
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 27, 2026 21:49